According to reports, the GoodRx platform, which helps consumers buy discounted prescription drugs, will be listed on the Nasdaq. The prospectus shows that the company achieved a net profit of $55 million in the first half of 2020, a year-on-year increase of 75%.

Under the epidemic, in addition to Zoom, the growth rate of GoodRx has also attracted the attention of Wall Street. Previously, GoodRx told CNBC that since 2013, the company has been profitable intermittently. From the relevant documents, GoodRx’s revenue in the first half of 2020 was US$257 million, a significant increase of 48% year-on-year.